• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWSBIOO:GR

136.48 EUR 0.58 0.43%

As of 01:59:30 ET on 07/25/2014.

Snapshot for DWS Biotech (DWSBIOO)

Year To Date: +15.53% 3-Month: +16.77% 3-Year: +35.21% 52-Week Range: 104.00 - 143.38
1-Month: +2.95% 1-Year: +24.18% 5-Year: +23.96% Beta vs NBI: 0.96

Mutual Fund Chart for DWSBIOO

No chart data available.
  • DWSBIOO:GR 136.48
  • 1M
  • 1Y
Interactive DWSBIOO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWSBIOO

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 08-16-1999 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWSBIOO

NAV (on 2014-07-31) 136.48
Assets (M) (on 2014-07-31) 301.14
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DWSBIOO

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DWSBIOO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.70

Top Fund Holdings for DWSBIOO

Filing Date: 05/30/2014
Name Position Value % of Total
Biogen Idec Inc 115,000 27,022,694 9.762%
Celgene Corp 450,000 25,333,534 9.152%
Gilead Sciences Inc 415,000 25,024,758 9.040%
Alexion Pharmaceuticals Inc 136,000 16,737,478 6.046%
Amgen Inc 174,000 14,828,311 5.357%
Vertex Pharmaceuticals Inc 228,250 12,209,173 4.411%
Regeneron Pharmaceuticals Inc 42,000 9,448,596 3.413%
Jazz Pharmaceuticals Plc 90,000 9,432,551 3.408%
BioMarin Pharmaceutical Inc 210,000 8,870,980 3.205%
Alkermes PLC 220,086 7,450,567 2.692%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil